Feeds
German chemical and pharmaceutical company Bayer AG announced Tuesday that it has tapped Marijn Dekkers to take over as its chief executive in October 2010.
German drug and chemical maker Bayer AG reported Tuesday a 58 percent jump in fourth quarter net profit despite difficult market conditions, and said it expected further growth at its health care and crop science divisions in 2009.
Pharmaceutical and chemical maker Bayer AG has filed a federal lawsuit alleging that drugmaker Abbott Laboratories' best-selling drug, Humira, infringes on a decade-old Bayer patent.
Pharmaceutical and chemical maker Bayer AG said Friday the company would increase its research and development spending above the current euro2.8 billion ($3.75 billion) and called on the government for tax breaks for such spending.
Drug and chemical company Bayer AG said Wednesday that its third-quarter profit fell 76 percent on higher costs for energy and raw materials in what it termed a difficult market, but confirmed its guidance for the rest of 2008.
Heart surgery patients were more likely to die if given the anti-bleeding drug Trasylol, two more U.S. studies have found, renewing the claims that the drug is dangerous. Bayer AG stopped selling the drug last fall, after a Canadian study was halted because of deaths among patients taking Trasylol.
Bayer AG said Tuesday that its third-quarter profit nearly quadrupled with help from a massive tax gain, and the drug and chemical maker lifted its sales outlook for the year.
The Food and Drug Administration said Thursday that accumulating evidence suggests a Bayer AG drug used to prevent excessive bleeding during heart bypass surgery increases the risk of death when compared with other drugs.
Bayer AG said Thursday its fourth-quarter earnings surged, buoyed by strong growth in its health care business, and the drug and chemical maker forecast that annual group sales would rise at least 5 percent as it benefits from the acquisition of rival Schering AG.
The drugmaker Bayer AG said Friday that it will cut 6,100 jobs, or 5.5 percent of its work force, as it integrates Schering AG into its health care unit. More than half of the cuts will be in Europe, but about 1,000 positions will be eliminated in the United States.
FDA Killed 22,000 By Delaying Bayer Drug RecallThe lives of 22,000 patients could have been saved if U.S. regulators had been quicker to remove a Bayer AG drug used to stem bleeding during open heart surgery, according to a medical researcher interviewed by CBS Television's 60 Minutes program.
EU set to decide on compulsory tests for GMO riceEU regulators will decide this week whether to force testing of all U.S. long-grain rice imports to prove the absence of a genetically modified (GMO) strain not allowed in Europe, an official said on Monday.
Log In | Register
